3-Amino-1-Adamantanol CAS 702-82-9 Ubunyulu > 99.0% (HPLC) Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 3-Amino-1-Adamantanol

CAS: 702-82-9

Imbonakalo: Umgubo weCrystalline oMhlophe

Ubunyulu: >99.0% (HPLC) (isiseko esomileyo)

I-API ephakathi (i-CAS 274901-16-5) kunyango lwe-Type 2 Diabetes Mellitus (T2DM)

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

AbaPhakathi abaNxulumene noBonelelo loMvelisi:
CAS: 274901-16-5
3-Amino-1-Adamantanol CAS: 702-82-9
L-Prolinamide CAS: 7531-52-4
I-Boc-L-Proline CAS: 15761-39-4
(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile CAS: 207557-35-5

Iipropati zeMichiza:

Igama leMchiza	3-Amino-1-Adamanol
Izithethantonye	I-1-Amino-3-Hydroxyadamantane;I-3-Amino-1-Hydroxyadamantane
Inombolo yeCAS	702-82-9
Inombolo yeCAT	RF-PI102
Ubume beStokhwe	Kwi-Stock, Umthamo weMveliso 800MT/Unyaka
Ifomula yeemolekyuli	C₁₀H₁₇NO
Ubunzima beMolekyuli	167.25
Ukunyibilika	I-Soluble kwi-Organic Solvents kunye ne-Intoluble emanzini
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMhlophe
Ubunyulu / Indlela yokuHlalutya	>99.0% (HPLC) (isiseko esomileyo)
Amanzi (nguKarl Fischer)	<0.50%
Intsalela kwi-Ignition	<0.50%
Indawo yokunyibilika	266.5℃~272.5℃
Ukungacoceki Okukodwa	<0.50%
Ukungcola ngokupheleleyo	<1.00%
I-Infrared Spectrum	Iyahambelana noLwakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	I-API ephakathi (CAS: 274901-16-5)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-3-Amino-1-Adamanol (i-CAS: 702-82-9) enomgangatho ophezulu.I-API (i-CAS: 274901-16-5) yenziwe i-3-Amino-1-Adamantanol.API (CAS: 274901-16-5)i-agent yomlomo ye-anti-hyperglycemic (i-anti-diabetic drug) ye-dipeptidyl peptidase-4 (DPP-4) inhibitor yeklasi entsha yamachiza.I-API (i-CAS: i-274901-16-5) inqanda ukungasebenzi kwe-GLP-1 kunye ne-GIP nge-DPP-4, ivumela i-GLP-1 kunye ne-GIP ukuba ikwazi ukukhupha i-insulin kwiiseli ze-beta kunye nokucinezela ukukhutshwa kweglucagon ngamaseli e-alpha. iziqithi zeLangerhans kwi-pancreas.Kuye kwaboniswa ukunciphisa i-hyperglycemia kuhlobo lwe-2 yesifo sikashukela.Yavunywa ngoFeb 2008 yi-Arhente yaMayeza yaseYurophu ukuba isetyenziswe ngaphakathi kwe-EU kwaye idweliswe kwi-PBS yase-Australia enezithintelo ezithile.